Precision Oncology Highlights From ESMO 2018

Feb

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

In this session, the second in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review cases in which patient genomic profiles exhibit common driver mutations in tumor types considered “off label” for targeted therapies associated with those mutations.

Mar

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

Menu

Precision Oncology Highlights From ESMO 2018

To read the full story....

Breaking News

Myriad Genetics Quarterly Revenues Decline 21 Percent

AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

ERS Genomics Licenses CRISPR Patents to Korean Biotech Firm G+FLAS Life Sciences

SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development

DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick

Recent Headlines from
Precision Oncology News

CAR T-Cell Resistance Mechanism Shows Need for Multi-Antigen Targeted Immunotherapy Strategies

Benefit of AstraZeneca's Cediranib Plus Lynparza May Be Limited to HRR-Deficient Prostate Cancers

Fecal Transplants Boost Immunotherapy Response in Subset of Melanoma Patients

Strata Oncology Launches Large Study Eyeing Competitive Cancer Monitoring, Drug Selection Test Space

With First-In-Class Iovance BLA Pending, TIL Therapies on Cusp of Commercialization

Featured White Papers

Virtual Molecular Tumor Board Series: Common Driver Mutations in ‘Off-Label’ Tumor Types

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

What's Popular?

Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test

Adaptive Biotechnologies, LabCorp Expand Collaboration

AnchorDx Closes $40M Series C Financing Round

AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

Multiple Myeloma Therapy Targets, Resistance Pathways Identified With Single-Cell Sequencing

Sponsorships